Premium
Surgery for hepatocellular carcinoma
Author(s) -
TAN KC
Publication year - 2002
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1046/j.1440-1746.17.s3.38.x
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , liver transplantation , resection , surgery , transplantation , milan criteria , therapeutic modalities , carcinoma , modalities , surgical resection , hepatectomy , general surgery , social science , sociology
Today there is an array of therapeutic modalities available for the patients with hepatocellular carcinoma (HCC). However, surgery, be it resection or transplantation, offers the only hope of long‐term disease‐free survival. Unfortunately, because the majority of HCC in Asia is associated with cirrhosis, surgical resection is restricted to only a small proportion of these patients. However, in selected candidates resection may offer a 5‐year survival of up to 70%. With the clinical application of adult‐to‐adult living donor liver transplantation, an increasing number of patients with small HCC and decompensating cirrhosis are undergoing transplantation. © 2002 Blackwell Publishing Asia Pty Ltd